{
    "id": "dbpedia_8013_1",
    "rank": 66,
    "data": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704081/",
        "read_more_link": "",
        "language": "en",
        "title": "Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research",
        "top_image": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "meta_img": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "images": [
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg",
            "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-jppp.png",
            "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/corrauth.gif",
            "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/corrauth.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Nasir Abbas",
            "Zaheer-Ud-Din Babar"
        ],
        "publish_date": "2021-08-18T00:00:00",
        "summary": "",
        "meta_description": "While having access to safe and efficient vaccines is essential for eradicating the COVID-19 pandemic, gaining marketing authorisation is a critical step in enabling and speeding this process. On December 2, 2020, the United Kingdom became the first country ...",
        "meta_lang": "en",
        "meta_favicon": "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico",
        "meta_site_name": "PubMed Central (PMC)",
        "canonical_link": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704081/",
        "text": "Introduction\n\nUnited Kingdom (UK) is the first country, where Pfizer-BioNTech COVID-19 Vaccine was approved on 02 December 2020 [1]. This has allowed UK population to access this much needed vaccine few weeks ahead of anyone else in the world [2]. This commentary aims to provide a quick summary of authorization process for the COVID-19 vaccines in the UK and compares the process with the EU and the US. Several COVID-19 vaccines have now been approved for use in humans [3]. In this commentary we have reviewed the authorization and review process of Pfizer-BioNTech COVID-19 Vaccine (mRNA Vaccine BNT162b2 concentrate for solution for injection) now branded as ComirnatyÂ®. This is first approved COVID-19 vaccine and has been approved for use in 112 countries so far, and 46 trials in 21 countries have been conducted [4]."
    }
}